2023
DOI: 10.1186/s40001-023-01271-8
|View full text |Cite
|
Sign up to set email alerts
|

Biological effects and mechanisms of fisetin in cancer: a promising anti-cancer agent

Chenhui Zhou,
Yi Huang,
Sheng Nie
et al.

Abstract: Fisetin, a natural flavonoid, possesses numerous biological activities that have been extensively studied in various diseases. When it comes to cancer, fisetin exhibits a range of biological effects, such as suppressing cell growth, triggering programmed cell death, reducing the formation of new blood vessels, protecting against oxidative stress, and inhibiting cell migration. Moreover, fisetin has the ability to enhance the effectiveness of chemotherapy. The anticancer properties of fisetin can be attributed … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 107 publications
0
1
0
Order By: Relevance
“…In cancer cells, however, fisetin exerts antiproliferative and pro-apoptotic effects via activation of both death receptor and mitochondrial-dependent pathways [ 73 , 74 ] and inhibits cell migration, metastatic activity, and angiogenesis [ 75 77 ]. The anticancer properties of fisetin can be attributed to regulation of several signaling pathways, including MAPK, NF-κB, PI3K/Akt/mTOR, vascular endothelial growth factor, and Nrf2/HO-1 (transcription factor nuclear factor erythroid 2-related factor 2/heme oxygenase 1) [ 78 ].…”
Section: Senotherapeuticsmentioning
confidence: 99%
“…In cancer cells, however, fisetin exerts antiproliferative and pro-apoptotic effects via activation of both death receptor and mitochondrial-dependent pathways [ 73 , 74 ] and inhibits cell migration, metastatic activity, and angiogenesis [ 75 77 ]. The anticancer properties of fisetin can be attributed to regulation of several signaling pathways, including MAPK, NF-κB, PI3K/Akt/mTOR, vascular endothelial growth factor, and Nrf2/HO-1 (transcription factor nuclear factor erythroid 2-related factor 2/heme oxygenase 1) [ 78 ].…”
Section: Senotherapeuticsmentioning
confidence: 99%